Format

Send to

Choose Destination
See comment in PubMed Commons below
AJR Am J Roentgenol. 2014 Aug;203(2):W146-57. doi: 10.2214/AJR.13.12420.

FDG PET/CT in the management of nasopharyngeal carcinoma.

Author information

1
1 Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, 601 N Caroline St, JHOC 3235, Baltimore, MD 21287.

Abstract

OBJECTIVE:

FDG PET/CT has a growing role in the diagnosis and management of nasopharyngeal carcinoma (NPC). FDG PET has greater efficacy for N and M staging than other modalities, which enables the treating oncologists to select the appropriate mode of treatment. FDG PET/CT helps in radiation therapy planning, provides valuable prognostic information, and is useful in the assessment of therapy response and in follow-up to detect recurrences.

CONCLUSION:

FDG PET/CT is a valuable imaging test in the management of NPC.

KEYWORDS:

PET/CT; nasopharyngeal cancer; patient outcome; radiation therapy planning

PMID:
25055290
DOI:
10.2214/AJR.13.12420
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center